Medical marijuana cardholders had less antiemetic overuse during cancer chemotherapy
Cancer patients with medical marijuana cards were 24% less likely to experience antiemetic overuse during chemotherapy compared to non-cardholders, suggesting cannabis may allow more appropriate antiemetic prescribing.
Quick Facts
What This Study Found
Medical marijuana cardholders had significantly lower odds of antiemetic overuse (aOR 0.76, p<0.05) compared to non-cardholders. Antiemetic overuse was identified in 7.5% of chemotherapy cycles overall.
Key Numbers
20,558 patients, 436 (2.1%) had MMJ cards. Antiemetic overuse in 7.5% of chemotherapy cycles. MMJ cardholders aOR 0.76 for overuse (p<0.05).
How They Did This
Retrospective cohort using linked Arkansas All Payers Claims Database (2013-2020) and medical marijuana cardholder registry (2013-2019). 20,558 cancer patients aged 18+ with outpatient chemotherapy within 12 months of diagnosis. Antiemetic overuse defined per ASCO Choosing Wisely recommendations.
Why This Research Matters
Antiemetic overuse during chemotherapy is a quality concern highlighted by ASCO. If cannabis can reduce unnecessary antiemetic prescribing while maintaining nausea control, it could improve chemotherapy care quality and reduce costs.
The Bigger Picture
This study approaches the cannabis-cancer question from a quality improvement angle rather than just symptom management. Reducing antiemetic overuse aligns with value-based care principles and could decrease side effects from unnecessary medications.
What This Study Doesn't Tell Us
Cardholder status does not mean patients actually used cannabis. Arkansas MMJ program may not represent other states. Cannot determine whether cannabis replaced antiemetics or if cardholder characteristics drove the difference. Small MMJ group (436 of 20,558).
Questions This Raises
- ?Are MMJ cardholders refusing antiemetics that they actually need?
- ?Does cannabis use during chemotherapy affect treatment adherence or cancer outcomes?
Trust & Context
- Key Stat:
- 24% lower odds of antiemetic overuse
- Evidence Grade:
- Population-based retrospective cohort with claims data linkage, but cannot confirm actual cannabis use and has a small cardholder group.
- Study Age:
- 2024 analysis of Arkansas claims and MMJ registry data from 2013-2020
- Original Title:
- Association Between Medical Marijuana Cardholder Status and Antiemetic Overuse.
- Published In:
- Cannabis and cannabinoid research (2024)
- Authors:
- Baltz, Alan P, Peng, Cheng, Gressler, Laura, Bhatti, Sajjad, Lewis, Kanna
- Database ID:
- RTHC-05109
Evidence Hierarchy
Frequently Asked Questions
What is antiemetic overuse?
Using more anti-nausea medications than recommended by clinical guidelines for the level of nausea risk from a specific chemotherapy regimen. ASCO identified this as a practice to reduce in their Choosing Wisely campaign.
Does this prove cannabis replaces anti-nausea drugs?
Not definitively. Having an MMJ card was associated with less overuse, but the study could not confirm patients actually used cannabis or determine the specific mechanism behind the association.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05109APA
Baltz, Alan P; Peng, Cheng; Gressler, Laura; Bhatti, Sajjad; Lewis, Kanna. (2024). Association Between Medical Marijuana Cardholder Status and Antiemetic Overuse.. Cannabis and cannabinoid research. https://doi.org/10.1089/can.2024.0083
MLA
Baltz, Alan P, et al. "Association Between Medical Marijuana Cardholder Status and Antiemetic Overuse.." Cannabis and cannabinoid research, 2024. https://doi.org/10.1089/can.2024.0083
RethinkTHC
RethinkTHC Research Database. "Association Between Medical Marijuana Cardholder Status and ..." RTHC-05109. Retrieved from https://rethinkthc.com/research/baltz-2024-association-between-medical-marijuana
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.